Physician profile
Ashley Jansen
NPI 1306083985
$9,477.03
in general payments reported to CMS, 2019-2025
27 companies · $1,361 in 2025
The $1,361 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $724 · 2022: $2,454 · 2023: $2,847 · 2024: $2,091 · 2025: $1,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,070 · Education: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,069.99 |
| Education | $229.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,374.25 | 2021-2025 | |
| Amgen INC. | $885.90 | 2021-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $863.83 | 2021-2025 | Tremfya |
| Genzyme Corporation | $591.77 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $527.56 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $472.99 | 2021-2025 | Winlevi, Ilumya |
| Incyte Corporation | $445.99 | 2022-2025 | Opzelura |
| Ucb, INC. | $390.97 | 2022-2025 | Bimzelx, Cimzia |
| Dermavant Sciences, INC. | $370.31 | 2022-2024 | Vtama |
| Pfizer INC. | $249.62 | 2022-2025 | |
| Lilly USA, LLC | $224.08 | 2022-2024 | Taltz, Olumiant |
| Leo Pharma INC. | $185.13 | 2022-2025 | Adbry |
| Mayne Pharma Commercial LLC | $149.58 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $138.20 | 2022-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $94.92 | 2023-2024 | Sotyktu |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $89.95 | 2024 | |
| Organon LLC | $70.80 | 2025 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.16 | 2023-2025 | Spevigo, Cyltezo |
| Galderma Laboratories, L.P. | $61.08 | 2023 | Aklief, Oracea, Twyneo |
| Organogenesis INC. | $50.14 | 2022-2025 | Via Matrix, Puraply |
| Almirall LLC | $36.41 | 2022 | |
| Strata Skin Sciences, INC. | $36.25 | 2022-2024 | Xtrac |
| Krystal Biotech INC | $23.85 | 2024 | Vyjuvek |
| Arcutis Biotherapeutics, INC. | $22.32 | 2024 | Zoryve |
| Biofrontera INC. | $22.18 | 2022 | |
| Botanix Sb INC | $17.25 | 2025 | Sofdra |
| Epi Health, LLC | $14.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Jansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.